Related Experiment Video
Updated: Apr 19, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
[Research advances on caspase-independent cell death of K562 cells]
1The First Clinicial Department, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China.
Abstract:
Caspase independent cell death (CICD) is defined as death that ensues when a signal that normally induces apoptosis fails to activate caspases,it can be activated by PARP-1, Calpains, Bax and AIF, possessing distinctive biologic characteristic differed from apoptosis and necrosis. Recent researchs have found that the molecular mechanisms governing CICD of K562 is opposite from that of the traditional medicine killing leukemia cells, which may have the potential pharmaceutical point for new drugs. This article reviews the newly acquaintance of molecular mechanisms for CICD and recent studies concerning the induction death of K562 cells via CICD, so as to provide some reference for the research of new drug point.
Insights
Caspase-independent cell death (CICD) offers a novel therapeutic strategy for leukemia. Understanding CICD mechanisms in K562 cells reveals distinct pathways from traditional treatments, highlighting potential new drug targets.
Area of Science:
- Cell Biology
- Molecular Mechanisms
- Cancer Research
Background:
- Caspase-independent cell death (CICD) is a distinct form of cell death.
- CICD can be activated by various factors including PARP-1, Calpains, Bax, and AIF.
- Its biological characteristics differ from apoptosis and necrosis.
Purpose of the Study:
- To review the molecular mechanisms of CICD.
- To discuss recent studies on CICD induction in K562 leukemia cells.
- To identify potential pharmaceutical targets for new anti-leukemia drugs.
Main Methods:
- Literature review of recent research on CICD.
- Analysis of molecular pathways involved in CICD.
- Examination of studies on K562 cell death induction.
Main Results:
- CICD mechanisms in K562 cells are opposite to traditional leukemia treatments.
- CICD presents unique biological characteristics.
- Specific molecular players like PARP-1, Calpains, Bax, and AIF are involved in CICD activation.
Conclusions:
- CICD represents a promising avenue for novel leukemia drug development.
- Targeting CICD pathways in K562 cells offers a new therapeutic strategy.
- Further research into CICD mechanisms can inform the development of effective anti-cancer drugs.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
The Extrinsic Apoptotic Pathway
Caspases
The Intrinsic Apoptotic Pathway
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

